Table 3 Analysis of VTE risk factors in patients with COVID-19
Past medical history | Add of studies | OR(95%CI) | P-value | Heterogeneity | p-value for publication bias | |
|---|---|---|---|---|---|---|
I2 | p-value | |||||
Respiratory disease | 27 | 1.11 (95% CI = 0.87–1.43) | 0.4 | 0.0 | 0.51 | 0.014 |
Cardiovascular disease | 35 | 1.17 (95% CI = 0.98–1.4) | 0.086 | 0.0 | 0.55 | 0.069 |
Hypertension | 34 | 0.92 (95% CI = 0.81–1.04) | 0.195 | 24.8 | 0.097 | 0.068 |
Diabetes | 35 | 0.98 (95% CI = 0.83–1.15) | 0.76 | 36.6 | 0.017 | 0.008 |
Dyslipidemia | 9 | 1.27 (95% CI = 0.96–1.68) | 0.095 | 0.0 | 0.55 | 0.037 |
Immunodeficiency | 3 | 0.52 (95% CI = 0.28–0.98) | 0.043 | 60.7 | 0.08 | 0.654 |
Kidney disease | 17 | 0.36 (95% CI = 0.26–0.5) | 0.000 | 30.5 | 0.11 | 0.907 |
Liver disease | 9 | 1.2 (95% CI = 0.56–2.6) | 0.63 | 0.0 | 0.62 | 0.669 |
Malignancy | 29 | 1.05 (95% CI = 0.82–1.36) | 0.68 | 4 | 0.4 | 0.067 |
Smoking | 19 | 1.02 (95% CI = 0.8–1.3) | 0.84 | 35.3 | 0.06 | 0.059 |
Stroke | 9 | 2.04 (95% CI = 1.09–3.8) | 0.025 | 0.0 | 0.83 | 0.412 |